Eosinophil levels and COPD flare-up outcomes
Part of Lungs & breathing clinical trials.
This study looks at how common a certain type of white blood cell (eosinophil) is in people with COPD during a flare-up, and whether it affects how they do over time. It may help doctors learn if measuring eosinophils can guide treatment for COPD flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 40 years old.
- You have been diagnosed with COPD (chronic lung disease).
- You are currently having a flare-up of your COPD (worsening symptoms for at least 2 days).
- You do not have asthma or a history of asthma.
- You have not taken steroid pills or shots in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how simple blood tests (red blood cells and platelets) can help predict how well people with a sudden worsening of COPD will do. It aims to find better ways to guide treatment.
This study looks at how to better measure the severity of a sudden COPD flare-up. It combines traditional Chinese medicine with standard tests to understand your condition.
This study is looking at people admitted to the hospital for a severe COPD flare-up. It checks if a low level of eosinophils (a type of white blood cell) in the blood is linked to how quickly you recover from the flare-up.
This study looks at people with COPD who have a sudden worsening of symptoms, called an exacerbation. It tracks what symptoms they have and how they do over time to help doctors understand better how to treat these episodes.
This study looks at how eosinophils, a type of white blood cell, relate to chronic lung conditions. It tests whether higher eosinophil levels are linked to certain types of lung disease, without the influence of steroids or antifibrotic drugs.
This trial tests if inhaled corticosteroids (ICS) work better for COPD patients with different eosinophil levels. You must already be taking two long-acting bronchodilators and have stopped smoking for at least 6 months.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.